Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

NCT05370885 is registered in ClinicalTrials.gov with Vedanta Biosciences, Inc. as lead sponsor.

NCT NCT05370885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05370885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Lead sponsor
Vedanta Biosciences, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
May 8, 2023
Completion date
August 29, 2025
Enrollment
114 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative, ulcerative colitis